Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhongyuan Union Stem Cell Bioengineering Co., Ltd.
Tianjin, Chinalinkedin.com ↗
- Ownership
- Private
- Employees
- ~2014
- Development stage
- Other
01
Overview
Zhongyuan Union Stem Cell Bioengineering Co., Ltd. (“中源协和”) specializes in precision medicine with a focus on the research, industrialization, storage/preparation of various human-derived stem/immune cells as well as genetic testing services. The company operates a national network for cell resource storage and has several clinical-stage programs including mesenchymal stem cell therapies (Phase II), CAR-T therapies targeting CD19+ malignancies (Phase I), and other investigational new drug applications. It also provides commercial diagnostic reagents/kits/services across China.
- Therapeutic areas
- OncologyImmunologyGastroenterology
- Modalities
- Stem cell therapy (including mesenchymal stem cells, cord blood hematopoietic stem cells, placental pluripotent stem cells, adipose-derived stem cells, immune cells)CAR-T cell therapyMonoclonal antibodies
- Industry
- Biotech
02
Partnerships
Notable JV/MOU with UK-based Cell Therapy Ltd. for stromal cell heart failure treatment ($8M JV capital); founded by Nobel laureate Sir Martin Evans.
Beyond the preview
Go deeper on Zhongyuan Union Stem Cell Bioengineering Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhongyuan Union Stem Cell Bioengineering Co., Ltd..